epcore nhl-2: epcoritamab with rituximab and lenalidomide in newly diagnosed and r/r fl
Published 1 year ago • 910 plays • Length 7:45Download video MP4
Download video MP3
Similar videos
-
8:06
findings from arms 6 and 7 of the epcore nhl-2 trial: epcoritamab in newly diagnosed fl
-
3:01
updated results from epcore nhl-2: epcoritamab plus gemox in patients with r/r dlbcl
-
1:49
follow-up results of epcore nhl-1: subcutaneous epcoritamab in r/r lbcl
-
1:38
phase ii study of epcoritamab in r/r lbcl
-
1:06
epcore nhl-1: two and a half year follow-up of epcoritamab in dlbcl
-
1:00
epcoritamab monotherapy and combinations in r/r cll and richter’s syndrome
-
1:11
epcoritamab combined with gemox in b-nhl: updated results from epcore nhl-2
-
2:42
results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct
-
4:28
i-doublediff & cora technologies - horiba yumizen h550e & yumizen h500e cbc esr analyzers
-
2:09:55
hematology tutorial for r2 internal medicine — part i
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
3:09
the role of epcoritamab in third-line or later lbcl
-
2:05
a phase ii study investigating epcoritamab in the treatment of waldenström’s macroglobulinemia
-
2:03
the current landscape of treatment for bpdcn
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:58
ash highlights: glofitamab in dlbcl & pirtobrutinib and epcoritamab in richter's transformation
-
9:41
subcutaneous epcoritamab in r/r b-cell non-hodgkin lymphoma